EUVIMEDEUVIMED entdecken
Open Access

Metabolic dormancy in Chlamydia trachomatis treated with different antibiotics

Daniel D Rockey iD, Xisheng Wang, Abigail Debrine, Nicole Grieshaber, Scott S Grieshaber iD

Infection and Immunity · 13.02.2024 · 92 (2)

DOI: 10.1128/iai.00339-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Immunity, erschienen am 13.02.2024. Verfasst von Daniel D Rockey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Oregon State University, Corvallis, Oregon, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Chlamydia Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diseases caused by Chlamydia spp. are often associated with persistent infections. Chlamydial persistence is commonly associated with a unique non-infectious intracellular developmental form, termed an aberrant form. Although infectious chlamydiae can be cultured consistently in cells stressed to aberrancy, their role in persistence is not clear. Recovery from antibiotic stress was explored as a model to determine how survival of non-aberrant chlamydiae, in the presence of fully inhibitory drug concentrations, may participate in persistence. Assays included incubation in quinolones, tetracyclines, or chloramphenicol for differing lengths of time, followed by an extended recovery period in antibiotic-free media. Culturable elementary bodies were not detected during treatment with each antibiotic, but viable and culturable Chlamydia trachomatis emerged after the drug was removed. Time-lapse imaging of live, antibiotic-treated infected cells identified metabolically dormant developmental forms within cells that emerged to form typical productive inclusions. The effects of the increasing concentration of most tested antibiotics led to predictable inhibitory activity, in which the survival rate decreased with increasing drug concentration. In contrast, in fluoroquinolone-treated cells, there was a paradoxical increase in productive development that was directly correlated with drug concentration and inversely associated with aberrant form production. This model system uncovers a unique chlamydial persistence pathway that does not involve the chlamydial aberrant form. The association between productive latency and metabolic dormancy is consistent with models for many bacterial species and may lead to a different interpretation of mechanisms of chlamydial persistence in patients. IMPORTANCE The life history of most pathogens within the genus Chlamydi a relies on lengthy persistence in the host. The most generally accepted model for Chlamydia spp. persistence involves an unusual developmental stage, termed the aberrant form, which arises during conditions that mimic a stressful host environment. In this work, we provide an alternate model for chlamydial persistence in the face of antibiotic stress. This model may be relevant to antibiotic treatment failures in patients infected with C. trachomatis .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsChlamydia InfectionsHumansChlamydia trachomatis

Stichwörter der Autor:innen

Chlamydiaantibiotic toleranceantibioticsdormancypersistencestress

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Oregon State University, Corvallis, Oregon, USA.
  • Department of Biological Sciences, University of Idaho, Moscow, Idaho, USA.

ORCID-Profile: Daniel D Rockey, Scott S Grieshaber

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • HHS | NIH | NIAID | Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Rockey, D. D., Wang, X., Debrine, A., Grieshaber, N., & Grieshaber, S. S. (2024). Metabolic dormancy in Chlamydia trachomatis treated with different antibiotics. Infection and Immunity, 92(2). https://doi.org/10.1128/iai.00339-23

Vancouver

Rockey DD, Wang X, Debrine A, Grieshaber N, Grieshaber SS. Metabolic dormancy in Chlamydia trachomatis treated with different antibiotics. Infection and Immunity. 2024;92(2). doi:10.1128/iai.00339-23

BibTeX
@article{Rockey2024,
  author = {Rockey, Daniel D and Wang, Xisheng and Debrine, Abigail and Grieshaber, Nicole and Grieshaber, Scott S},
  title = {Metabolic dormancy in Chlamydia trachomatis treated with different antibiotics},
  journal = {Infection and Immunity},
  year = {2024},
  volume = {92},
  number = {2},
  doi = {10.1128/iai.00339-23}
}
Kostenlos starten →